Adherence to Hospital Antibiotic Policy for Treatment of Escherichia coli ESBL in Urine.

about

Adherence to Hospital Antibiotic Policy for Treatment of Escherichia coli ESBL in Urine.

Item

http://www.wikidata.org/entity/Q36830992

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Adherence to Hospital Antibiotic Policy for Treatment of Escherichia coli ESBL in Urine.

@en

type

Item

label

Adherence to Hospital Antibiotic Policy for Treatment of Escherichia coli ESBL in Urine.

@en

prefLabel

Adherence to Hospital Antibiotic Policy for Treatment of Escherichia coli ESBL in Urine.

@en

P1476

Adherence to Hospital Antibiotic Policy for Treatment of Escherichia coli ESBL in Urine.

@en

P2093

Anbu N Aravazhi

http://www.w3.org/2001/XMLSchema#string

K Gnana Prakash

http://www.w3.org/2001/XMLSchema#string

R Someshwaran

http://www.w3.org/2001/XMLSchema#string

Shreeram A Deshpande

http://www.w3.org/2001/XMLSchema#string

P2860

Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia: comparison of data from 1997 and 1998 using the Etest method. The Colombian Antimicrobial Resistance Study Group.

Antibiotic administration in patients undergoing common surgical procedures in a community teaching hospital: the chaos continues.

Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.

Comparison of extended spectrum β-lactamases-producing Escherichia coli with non-ESBLs-producing E.coli: drug-resistance and virulence.

Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli

Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria.

Pivmecillinam--therapy of choice for lower urinary tract infection.

P304

DC01-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7860/JCDR/2016/16084.7382

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27134869

http://www.w3.org/2001/XMLSchema#string

P932

4843255

http://www.w3.org/2001/XMLSchema#string